Global Women’s Health Diagnostics Market to Growth by a CAGR of ~7%

Research Nester published a report titled “Women’s Health Diagnostics Market: Global Demand Analysis & Opportunity Outlook 2031” which delivers detailed overview of the global women’s health diagnostics market in terms of market segmentation by application, end user, and by region.

Further, for the in-depth analysis, the report encompasses the industry growth indicators, restraints, supply and demand risk, along with detailed discussion on current and future market trends that are associated with the growth of the market.

The Women’s Health Diagnostics Market is estimated to occupy a large amount of revenue by growing at a CAGR of ~7% during the forecast period, i.e., 2022 – 2031, ascribing to the rising occurrence of lifestyle and chronic diseases among women, and growing awareness regarding several health disorders around the world. Along with this, increasing prevalence of infectious disorders such as hepatitis and HIV in women, and escalating regulatory approvals for immunoassays from medical bodies globally are also expected to accelerate the growth of the market in the forthcoming years.

The market is segmented by application and end user. Based on application, the breast cancer segment is anticipated to acquire the largest share during the forecast period on the back of the rising burden of breast cancer, and surging investments in research and development activities for cancer diagnosis. Additionally, by end user, the home care segment is projected to observe robust growth over the forecast period attributing to the rising preference for using self-testing kits among women globally to test conditions such as ovulation and pregnancy.

Geographically, the global women’s health diagnostics market is segmented into five major regions, namely North America, Europe, Latin America, Asia Pacific, and the Middle East & Africa. North America is evaluated to grab the largest share in the market during the forecast period attributing to the escalating incidences of cancer amongst women, and growing demand for fertility test monitors in the region. Moreover, the market in Asia Pacific is assessed to witness noteworthy growth over the forecast period ascribing to the large patient pool, and developments in the healthcare infrastructure in the region.

The research is global in nature and covers detailed analysis on the market in North America (U.S., Canada), Europe (U.K., Germany, France, Italy, Spain, Hungary, Belgium, Netherlands & Luxembourg, NORDIC [Finland, Sweden, Norway, Denmark], Poland, Turkey, Russia, Rest of Europe), Latin America (Brazil, Mexico, Argentina, Rest of Latin America), Asia-Pacific (China, India, Japan, South Korea, Indonesia, Singapore, Malaysia, Australia, New Zealand, Rest of Asia-Pacific), Middle East and Africa (Israel, GCC [Saudi Arabia, UAE, Bahrain, Kuwait, Qatar, Oman], North Africa, South Africa, Rest of Middle East and Africa). In addition, analysis comprising market size, Y-O-Y growth & opportunity analysis, market players’ competitive study, investment opportunities, demand for future outlook etc. has also been covered and displayed in the research report.

Growing Prevalence of Lifestyle and Chronic Diseases Amongst Women Globally to Bolster Market Growth

Since the last two decades, the prevalence of chronic diseases among women has witnessed an upsurge as a result of rising adoption of sedentary lifestyle changes. This is raising the demand for advanced diagnostics systems for appropriate evaluation of the disease, which in turn is anticipated to accelerate the growth of the market significantly in the near future. 

However, high cost of diagnostic imaging systems and procedures is expected to operate as key restraint to the growth of the global women’s health diagnostics market over the forecast period.

This report also provides the existing competitive scenario of some of the key players of the global women’s health diagnostics market which includes company profiling of Siemens AG, F. Hoffmann-La Roche Ltd., Cardinal Health, Inc., General Electric Company, Hologic, Inc., Becton, Dickinson and Company, Quest Diagnostics, Inc., PerkinElmer Inc., Alere Inc., Biomérieux SA, and others. The profiling enfolds key information of the companies which encompasses business overview, products and services, key financials and recent news and developments. On the whole, the report depicts detailed overview of the global women’s health diagnostics market that will help industry consultants, equipment manufacturers, existing players searching for expansion opportunities, new players searching possibilities and other stakeholders to align their market centric strategies according to the ongoing and expected trends in the future. 

Leave a Reply

Your email address will not be published. Required fields are marked *